tiprankstipranks
Trending News
More News >
Modalis Therapeutics Corporation (JP:4883)
:4883
Japanese Market

Modalis Therapeutics Corporation (4883) Financial Statements

Compare
3 Followers

Modalis Therapeutics Corporation Financial Overview

Modalis Therapeutics Corporation's market cap is currently ¥5.29B. The company's EPS TTM is ¥-10.13; its P/E ratio is -2.21; Modalis Therapeutics Corporation is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 0.00¥ 0.00¥ 40.50M¥ 1.10M¥ 342.00M
Gross Profit¥ 0.00¥ -731.00K¥ -83.17M¥ 1.10M¥ 342.00M
Operating Income¥ -1.34B¥ -2.37B¥ -2.06B¥ -1.24B¥ -398.35M
EBITDA¥ -2.15B¥ -2.37B¥ -2.58B¥ -667.55M¥ -381.96M
Net Income¥ -1.32B¥ -2.39B¥ -2.70B¥ -738.96M¥ -448.41M
Balance Sheet
Cash & Short-Term Investments¥ 3.58B¥ 1.88B¥ 2.93B¥ 4.94B¥ 5.42B
Total Assets¥ 3.69B¥ 2.03B¥ 3.13B¥ 6.07B¥ 6.28B
Total Debt¥ 0.00¥ 412.50M¥ 0.00¥ 0.00¥ 0.00
Net Debt¥ -3.58B¥ -1.47B¥ -2.93B¥ -4.94B¥ -5.42B
Total Liabilities¥ 143.47M¥ 645.50M¥ 188.60M¥ 519.92M¥ 70.16M
Stockholders' Equity¥ 3.55B¥ 1.38B¥ 2.94B¥ 5.55B¥ 6.21B
Cash Flow
Free Cash Flow¥ -1.43B¥ -2.29B¥ -2.09B¥ -854.58M¥ -1.21B
Operating Cash Flow¥ -1.43B¥ -2.25B¥ -1.90B¥ -747.47M¥ -376.57M
Investing Cash Flow¥ -188.00K¥ -39.70M¥ -185.72M¥ 171.56M¥ -830.31M
Financing Cash Flow¥ 3.04B¥ 1.22B¥ 63.68M¥ 72.63M¥ 2.78B
Currency in JPY

Modalis Therapeutics Corporation Earnings and Revenue History

Modalis Therapeutics Corporation Debt to Assets

Modalis Therapeutics Corporation Cash Flow

Modalis Therapeutics Corporation Forecast EPS vs Actual EPS